Fingerprint
Dive into the research topics of 'Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
B van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, M S Paats, K Monkhorst, D A M Heideman, M Groves, T Radonic, E F Smit, E Schuuring, A J van der Wekken, A J de Langen*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
79
Citations
(Scopus)
170
Downloads
(Pure)